Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells (Q48240482)

9 February 2018

title

Treatment of Collagen-Induced Arthritis Using Immune Modulatory Properties of Human Mesenchymal Stem Cells (English)

1 reference

9 February 2018

author name string

Kyu-Hyung Park

1 reference

9 February 2018

Chin Hee Mun

1 reference

9 February 2018

Mi-Il Kang

1 reference

9 February 2018

Sang-Won Lee

1 reference

9 February 2018

Soo-Kon Lee

1 reference

9 February 2018

Yong-Beom Park

1 reference

9 February 2018

publication date

7 April 2015

1 reference

9 February 2018

published in

Cell Transplantation

1 reference

9 February 2018

volume

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

1057-1072

1 reference

9 February 2018

Helios expression is a marker of T cell activation and proliferation.

cites work

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mesenchymal stem cells in arthritic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mesenchymal stem cells: biology and potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

A comparison of adipose and bone marrow-derived mesenchymal stromal cell secreted factors in the treatment of systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Allogeneic mesenchymal stem cells: agents of immune modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Multipotent mesenchymal stromal cells and the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Bortezomib attenuates murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mesenchymal stem cells avoid allogeneic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Standardization of immunohistochemistry for formalin-fixed, paraffin-embedded tissue sections based on the antigen-retrieval technique: from experiments to hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3727%2F096368915X687949

21 January 2018

Identifiers

DOI

10.3727/096368915X687949

1 reference

9 February 2018

1 reference

9 February 2018